Reuters -- Genzyme Corp and U.S. regulators have agreed on a plan that could lead to approval of the company’s Pompe disease drug Lumizyme, Genzyme said on Thursday.
Reuters -- Genzyme Corp and U.S. regulators have agreed on a plan that could lead to approval of the company’s Pompe disease drug Lumizyme, Genzyme said on Thursday.
